Product Name: Human c-Met / HGFR Antibody (Emibetuzumab, Research Use)
Catalog Number: NBR-0202
Target Name: c-Met / HGFR
Trade Name: Emibetuzumab
Antibody Drug Description: Emibetuzumab (INN[1]) (LY2875358) is a humanized monoclonal antibody designed for the treatment of cancer. It is in phase II trials for patients with NSCLC. Appearance: Transparent Liquid
Molecular Weight: ~150kDa
CAS：N/A
Solubility: Water; PBS, TBS Buffer etc.
Expression System: CHO Expressed
Isotype of Ab: Ab. Isotype - IgG

  Gene Name: c-Met / HGFR
Synonyms: DFNB97; HGFR; RCCP2
Target Description: Receptor tyrosine kinase that transduces signals from the extracellular matrix into the cytoplasm by binding to hepatocyte growth factor/HGF ligand.
Ensembl: ENSG00000105976
Uniprot: P08581